DENDREON CORP·4

Jul 25, 1:10 PM ET

DENDREON CORP 4

4 · DENDREON CORP · Filed Jul 25, 2011

Insider Transaction Report

Form 4
Period: 2011-07-21
URDAL DAVID
SVP, Chief Scientific Officer
Transactions
  • Sale

    Common Stock

    2011-07-21$38.75/sh1,015$39,331576,080 total
Footnotes (1)
  • [F1]The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person

Documents

2 files
  • 4
    c20326_4x1.xmlPrimary

    MAIN DOCUMENT DESCRIPTION

  • EX-24

    POWER OF ATTORNEY